Shanghai Labway Clinical Laboratory Co., Ltd Stock price
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12 CNY | +3.36% | -14.59% | -9.71% |
Sales 2021 | 1.78B 246M | Sales 2022 | 4.2B 582M | Capitalization | 7.85B 1.09B |
---|---|---|---|---|---|
Net income 2021 | 204M 28.26M | Net income 2022 | 617M 85.48M | EV / Sales 2021 | 7.42 x |
Net cash position 2021 | 707M 97.97M | Net cash position 2022 | 421M 58.35M | EV / Sales 2022 | 1.77 x |
P/E ratio 2021 |
60.1
x | P/E ratio 2022 |
12.7
x | Employees | 1,878 |
Yield 2021 |
0.86% | Yield 2022 |
1.53% | Free-Float | 32.29% |
1 day | +3.36% | ||
1 week | -14.59% | ||
Current month | +18.46% | ||
1 month | +22.32% | ||
3 months | -8.68% | ||
6 months | -16.61% | ||
Current year | -9.71% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 15-08-19 |
Xi Gu Wang
DFI | Director of Finance/CFO | 54 | 22-07-21 |
Zhi Sen Mao
BRD | Director/Board Member | 64 | 21-12-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lei Wang
BRD | Director/Board Member | 42 | 21-12-16 |
Zhi Hua He
BRD | Director/Board Member | 61 | 15-08-19 |
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 15-08-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 12 | +3.36% | 12,871,570 |
24-03-27 | 11.61 | -2.27% | 17,659,530 |
24-03-26 | 11.88 | -1.57% | 12,607,730 |
24-03-25 | 12.07 | -8.91% | 20,446,160 |
24-03-22 | 13.25 | -5.69% | 28,671,280 |
End-of-day quote Shenzhen S.E., March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-9.71% | 665M | |
-8.32% | 9.21B | |
-9.54% | 3.67B | |
+39.95% | 3.59B | |
-4.12% | 2.6B | |
-12.21% | 2.25B | |
-2.84% | 2.01B | |
-16.85% | 1.63B | |
-25.37% | 1.54B | |
-7.98% | 1.12B |